Mervyn Maze
15Patents
6h-index
22Co-inventors
66Inventor score
Filing activity: Jan 13, 1993 → Dec 20, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6567702B1 | Eliciting analgesia by transcranial electrical stimulation | Human Necessities | 140 | Expired |
| US6653354B2 | NMDA antagonist comprising xenon | Human Necessities | 20 | Expired |
| US6562855B1 | Anaesthetic formulation comprising an NMDA-antagoinst and an alpha-2 adrenergic agonist | Human Necessities | 16 | Expired |
| US5344840A | 4-substituted imidazole derivatives useful in perioperative care | Human Necessities | 15 | Expired |
| US6274633A | NMDA antagonist | Human Necessities | 15 | Expired |
| US9708247B2 | Modulators of the eIF2alpha pathway | Chemistry; Metallurgy | 14 | Active |
| US10343981B2 | Modulators of the eIF2alpha pathway | Chemistry; Metallurgy | 6 | Active |
| US7390508B2 | Use of xenon with hypothermia for treating neonatal asphyxia | Human Necessities | 6 | Expired |
| US7632872B2 | Analgesic agent for newborn or fetal subjects | Human Necessities | 5 | Expired |
| US7442383B2 | Use of xenon for the control of neurological deficits associated with cardiopulmonary bypass | Human Necessities | 4 | Expired |
| US9308254B2 | Method for treatment of post operative cognitive dysfunction | Chemistry; Metallurgy | 4 | Active |
| US11220540B2 | Methods for reducing post-operative cognitive dysfunction (POCD) | Chemistry; Metallurgy | 1 | Active |
| US11220477B2 | Modulators of the eIF2alpha pathway | Chemistry; Metallurgy | 0 | Active |
| US12325744B2 | Methods for reducing post-operative cognitive dysfunction (POCD) | Chemistry; Metallurgy | 0 | Active |
| US9326996B2 | Use of xenon as neuroprotectant in a neonatal subject | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.